Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Novel Influenza A”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Large-scale testing (Phase 3)Study completedNCT00973700
What this trial is testing

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)

Who this might be right for
Novel 2009 Influenza H1N1
Novartis Vaccines 784
Not applicableStudy completedNCT01046734
What this trial is testing

Virus Shedding and Environmental Deposition of a Novel Influenza Virus

Who this might be right for
Novel (H1N1) Influenza
University of Nottingham 105
Testing effectiveness (Phase 2)Study completedNCT00975572
What this trial is testing

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older

Who this might be right for
Virus DiseasesRespiratory Tract DiseasesRespiratory Tract Infections+2 more
Jiangsu Province Centers for Disease Control and Prevention 2,200
Not applicableStudy completedNCT01617317
What this trial is testing

H-IVIG Treatment for Severe H1N1 2009

Who this might be right for
Novel 2009 Influenza A (H1N1) Infection
The University of Hong Kong 34
Early research (Phase 1)Active Not RecruitingNCT07019883
What this trial is testing

Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults

Who this might be right for
Avian Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT07225959
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Occurrence of Anti-Drug Antibodies Following Annual Doses of CD388

Who this might be right for
Healthy Participants
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 400
Post-approval studies (Phase 4)Study completedNCT03564444
What this trial is testing

D2560C00015 FluMist Annual Safety Study 2018

Who this might be right for
InfluenzaHealthy
MedImmune LLC 300
Post-approval studies (Phase 4)Study completedNCT01079273
What this trial is testing

Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects

Who this might be right for
Influenza
Opera CRO, a TIGERMED Group Company 7
Not applicableStudy completedNCT00404664
What this trial is testing

Improving Influenza Vaccination Rates Among Health Care Professionals

Who this might be right for
Influenza
The Cleveland Clinic 800
Not applicableStudy completedNCT02525055
What this trial is testing

Characterisation of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Who this might be right for
Influenza
Hvivo 46
Testing effectiveness (Phase 2)Study completedNCT00980850
What this trial is testing

Swine Flu (Novel Influenza A H1N1) Vaccine Study

Who this might be right for
Influenza
University of Oxford 1,000
Not applicableStudy completedNCT01040741
What this trial is testing

Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Who this might be right for
Pandemic Influenza A (H1N1)A New Flu Virus of Swine Origin
Novartis Vaccines 7,284
Large-scale testing (Phase 3)Study completedNCT00125944
What this trial is testing

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Who this might be right for
HealthyInfluenza
MedImmune LLC 300
Large-scale testing (Phase 3)Study completedNCT02207413
What this trial is testing

Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children

Who this might be right for
Influenza
GlaxoSmithKline 1,886
Early research (Phase 1)Looking for participantsNCT07044544
What this trial is testing

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

Who this might be right for
Myeloid MalignancyHematologic MalignancyAcute Myeloid Leukemia+1 more
University of Alabama at Birmingham 20
Testing effectiveness (Phase 2)Study completedNCT00197301
What this trial is testing

Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy

Who this might be right for
Influenza
Hadassah Medical Organization 200
Large-scale testing (Phase 3)Study completedNCT01031719
What this trial is testing

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Who this might be right for
H1N1 Influenza VirusInvasive Solid Tumors
Chiltern Pesquisa Clinica Ltda 59
Not applicableStudy completedNCT01046331
What this trial is testing

Novel Influenza A (H1N1) Surveillance Registry

Who this might be right for
Novel Influenza AH1N1Influenza
National Heart, Lung, and Blood Institute (NHLBI) 894
Not applicableStudy completedNCT05797103
What this trial is testing

The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus

Who this might be right for
Bacterial GrowthNovel Influenza A (H1N1)
Dove Medical Press Ltd 20
Post-approval studies (Phase 4)Study completedNCT00586469
What this trial is testing

Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk

Who this might be right for
Influenza Vaccines
GlaxoSmithKline 1,000
Load More Results